天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 164513-39-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 164513-39-7
Chemical Structure| 164513-39-7
Structure of 164513-39-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 164513-39-7 ]

Related Doc. of [ 164513-39-7 ]

Alternatived Products of [ 164513-39-7 ]
Product Citations

Product Details of [ 164513-39-7 ]

CAS No. :164513-39-7 MDL No. :MFCD04039980
Formula : C7H8BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :HTBPXLJKMNBQMS-UHFFFAOYSA-N
M.W : 202.05 Pubchem ID :4178002
Synonyms :

Calculated chemistry of [ 164513-39-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.29
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.39
TPSA : 22.12 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.96 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.35
Log Po/w (XLOGP3) : 2.21
Log Po/w (WLOGP) : 2.16
Log Po/w (MLOGP) : 1.65
Log Po/w (SILICOS-IT) : 2.46
Consensus Log Po/w : 2.17

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.86
Solubility : 0.277 mg/ml ; 0.00137 mol/l
Class : Soluble
Log S (Ali) : -2.31
Solubility : 0.992 mg/ml ; 0.00491 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.4
Solubility : 0.081 mg/ml ; 0.000401 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.8

Safety of [ 164513-39-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 164513-39-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 164513-39-7 ]
  • Downstream synthetic route of [ 164513-39-7 ]

[ 164513-39-7 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 164513-39-7 ]
  • [ 503184-35-8 ]
YieldReaction ConditionsOperation in experiment
56.6%
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1 h; Inert atmosphere
Stage #2: With Triisopropyl borate In tetrahydrofuran; hexane at 20℃;
[0107] Butyllithium solution (1.6M in hexane, 15.3 ml, 22.27 mmol) was added under argon to a solution of 5-bromo-2-methoxy-4-methylpyridine (4.5 g, 22.3 mmol) in 150 ml tetrahydrofuran at -78°C. The mixture was stirred at -78°C for 1h and after that triisopropyl borate (6.2 ml, 26.7 mmol) was added. The reaction was warmed to room temperature slowly and stirred overnight. The mixture was poured into a saturated aqueous ammonium chloride solution / water (1/1) and it was extracted with ethyl acetate, organic layers were put together, washed with brine, dried and concentrated. After washing the crude residue with diethyl ether the title compound was obtained as a white solid (2.12 g, 56.6percent yield). LRMS (m/z): 168 (M+1)+
Reference: [1] Bioorganic and medicinal chemistry letters, 2003, vol. 13, # 2, p. 289 - 291
[2] Patent: EP2738172, 2014, A1, . Location in patent: Paragraph 0107
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 164513-39-7 ]

Bromides

Chemical Structure| 164513-38-6

[ 164513-38-6 ]

5-Bromo-2-hydroxy-4-methylpyridine

Similarity: 0.91

Chemical Structure| 13472-85-0

[ 13472-85-0 ]

5-Bromo-2-methoxypyridine

Similarity: 0.89

Chemical Structure| 760207-87-2

[ 760207-87-2 ]

5-Bromo-2-methoxy-3-methylpyridine

Similarity: 0.88

Chemical Structure| 83664-33-9

[ 83664-33-9 ]

2-(Benzyloxy)-5-bromopyridine

Similarity: 0.87

Chemical Structure| 870521-31-6

[ 870521-31-6 ]

5-Bromo-2-isopropoxypyridine

Similarity: 0.85

Ethers

Chemical Structure| 13472-85-0

[ 13472-85-0 ]

5-Bromo-2-methoxypyridine

Similarity: 0.89

Chemical Structure| 760207-87-2

[ 760207-87-2 ]

5-Bromo-2-methoxy-3-methylpyridine

Similarity: 0.88

Chemical Structure| 83664-33-9

[ 83664-33-9 ]

2-(Benzyloxy)-5-bromopyridine

Similarity: 0.87

Chemical Structure| 870521-31-6

[ 870521-31-6 ]

5-Bromo-2-isopropoxypyridine

Similarity: 0.85

Chemical Structure| 1332324-22-7

[ 1332324-22-7 ]

3,5-Dibromo-2-methoxy-4-methylpyridine

Similarity: 0.84

Related Parent Nucleus of
[ 164513-39-7 ]

Pyridines

Chemical Structure| 164513-38-6

[ 164513-38-6 ]

5-Bromo-2-hydroxy-4-methylpyridine

Similarity: 0.91

Chemical Structure| 13472-85-0

[ 13472-85-0 ]

5-Bromo-2-methoxypyridine

Similarity: 0.89

Chemical Structure| 760207-87-2

[ 760207-87-2 ]

5-Bromo-2-methoxy-3-methylpyridine

Similarity: 0.88

Chemical Structure| 83664-33-9

[ 83664-33-9 ]

2-(Benzyloxy)-5-bromopyridine

Similarity: 0.87

Chemical Structure| 870521-31-6

[ 870521-31-6 ]

5-Bromo-2-isopropoxypyridine

Similarity: 0.85

; ;